BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23173966)

  • 1. Peri-procedural care of renal nerve ablation candidates.
    Tsioufis C; Dimitriadis K; Thomopoulos C; Tsiachris D; Kasiakogias A; Kintis K; Flesas D; Papademetriou V; Stefanadis C
    Curr Clin Pharmacol; 2013 Aug; 8(3):217-23. PubMed ID: 23173966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiofrequency sympathetic renal denervation: a new version of the old method of treatment resistant hypertension].
    Shavarov AA; Maĭskov VV; Kobalava ZhD
    Kardiologiia; 2013; 53(1):72-8. PubMed ID: 23548354
    [No Abstract]   [Full Text] [Related]  

  • 3. Current technologies: an introduction.
    Daemen J
    EuroIntervention; 2013 May; 9 Suppl R():R75-82. PubMed ID: 23732160
    [No Abstract]   [Full Text] [Related]  

  • 4. Updated ESH position paper on interventional therapy of resistant hypertension.
    Schmieder RE; Redon J; Grassi G; Kjeldsen SE; Mancia G; Narkiewicz K; Parati G; Ruilope L; van de Borne P; Tsioufis C;
    EuroIntervention; 2013 May; 9 Suppl R():R58-66. PubMed ID: 23732157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal denervation: a plea for wisdom.
    Lantelme P; Courand PY; Pathak A
    Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-up, study design and outcome parameters.
    Volpe M; Battistoni A; Tocci G
    EuroIntervention; 2013 May; 9 Suppl R():R96-100. PubMed ID: 23732163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients.
    Rabbia F; Testa E; Fulcheri C; Berra E; Di Monaco S; Covella M; Pappaccogli M; Monticone S; Rosiello R; Rossato D; Veglio F
    High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):187-192. PubMed ID: 28374154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response and non-response to renal denervation: who is the ideal candidate?
    Ukena C; Cremers B; Ewen S; Böhm M; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R54-7. PubMed ID: 23732156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
    Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal sympathetic nerve denervation for the treatment of resistant hypertension.
    Palmer SC; Judkins C; Williams PD; Whitbourn RJ
    Med J Aust; 2013 Aug; 199(3):160-2. PubMed ID: 23909527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenging anatomy, how to treat or not to treat?
    Zeller T; Rastan A; Macharzina R; Noory E
    EuroIntervention; 2013 May; 9 Suppl R():R67-74. PubMed ID: 23732158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal sympathetic nerve ablation for treatment-resistant hypertension.
    Krum H; Schlaich M; Sobotka P
    Br J Clin Pharmacol; 2013 Oct; 76(4):495-503. PubMed ID: 23819768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal artery denervation for treating resistant hypertension : definition of the disease, patient selection and description of the procedure.
    Volpe M; Rosei EA; Ambrosioni E; Cottone S; Cuspidi C; Borghi C; De Luca N; Fallo F; Ferri C; Mancia G; Morganti A; Muiesan ML; Sarzani R; Sechi L; Tocci G; Virdis A;
    High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):237-44. PubMed ID: 23430669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of renal nerve ablation for the management of resistant hypertension and other disease conditions: benefits and concerns.
    Faselis C; Doumas M; Kokkinos P; Tsioufis C; Papademetriou V
    Curr Vasc Pharmacol; 2014 Jan; 12(1):38-46. PubMed ID: 23905598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal denervation a new treatment option in resistant arterial hypertension].
    Himmel F; Bode F; Schunkert H; Weil J
    Praxis (Bern 1994); 2011 Nov; 100(22):1353-60. PubMed ID: 22048911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
    Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
    JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?
    Laffin LJ; Bakris GL
    Am J Hypertens; 2017 Sep; 30(9):841-846. PubMed ID: 27838622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.
    Ammar S; Ladich E; Steigerwald K; Deisenhofer I; Joner M
    EuroIntervention; 2013 May; 9 Suppl R():R89-95. PubMed ID: 23732162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.